Búsqueda Imágenes Maps Play YouTube Noticias Gmail Drive Más »
Iniciar sesión
Usuarios de lectores de pantalla: deben hacer clic en este enlace para utilizar el modo de accesibilidad. Este modo tiene las mismas funciones esenciales pero funciona mejor con el lector.

Patentes

  1. Búsqueda avanzada de patentes
Número de publicaciónUS20070032834 A1
Tipo de publicaciónSolicitud
Número de solicitudUS 11/407,684
Fecha de publicación8 Feb 2007
Fecha de presentación20 Abr 2006
Fecha de prioridad13 Jul 2000
También publicado comoCA2463751A1, EP1438100A1, US7305268, US7945330, US8195300, US8412335, US20040158298, US20090093862, US20110208264, US20120253421, WO2003043690A1
Número de publicación11407684, 407684, US 2007/0032834 A1, US 2007/032834 A1, US 20070032834 A1, US 20070032834A1, US 2007032834 A1, US 2007032834A1, US-A1-20070032834, US-A1-2007032834, US2007/0032834A1, US2007/032834A1, US20070032834 A1, US20070032834A1, US2007032834 A1, US2007032834A1
InventoresBradford Gliner, Jeffrey Balzer, Andrew Firlik
Cesionario originalNorthstar Neuroscience, Inc.
Exportar citaBiBTeX, EndNote, RefMan
Enlaces externos: USPTO, Cesión de USPTO, Espacenet
Systems and methods for automatically optimizing stimulus parameters and electrode configurations for neuro-stimulators
US 20070032834 A1
Resumen
Methods and devices for automatically optimizing the stimulus parameters and/or the configuration of electrodes to provide neural stimulation to a patient. In one embodiment, a system includes an electrode array having an implantable support member configured to be implanted into a patient and a plurality of therapy electrodes carried by the support member. The system can also have a pulse system operatively coupled to the therapy electrodes to deliver a stimulus to the therapy electrodes, and a sensing device configured to be attached to a sensing location of the patient. The sensing device generates response signals in response to the stimulus. The system can also include a controller operatively coupled to the pulse system and to the sensing device. The controller includes a computer operable medium that generates command signals that define the stimulus delivered by the pulse system, evaluates the response signals from the sensing device, and determines a desired configuration for the therapy electrodes and/or a desired stimulus to be delivered to the therapy electrodes.
Imágenes(13)
Previous page
Next page
Reclamaciones(49)
1. A neuro-stimulation system, comprising:
an electrode array having an implantable support member configured to be implanted into a patient and a plurality of therapy electrodes carried by the support member;
a pulse system operatively coupled to the therapy electrodes, the pulse system delivering a stimulus to the therapy electrodes; and
a controller operatively coupled to the pulse system, the controller including a computer operable medium containing instructions that generate command signals that define the stimulus delivered by the pulse system and determine a desired configuration for the therapy electrodes and/or a desired stimulus to be delivered to the therapy electrodes based upon feedback input to the controller.
2. The system of claim 1 wherein the therapy electrodes are independently coupled to the pulse system such that the pulse system can activate and/or deactivate individual therapy electrodes.
3. The system of claim 1 wherein the pulse system and the electrode array are components of an integrated unit configured to be implanted in the patient at a stimulation site.
4. The system of claim 1 wherein the electrode array is configured to be implanted at a stimulation site in the patient and the pulse system is separate from the electrode array and configured to be implanted at a site in the patient remote from the stimulation site, and the pulse system being coupled to the electrode array by a conductive line implanted in the patient.
5. The system of claim 1 wherein the controller is configured to be external to the patient and the pulse system is configured to be implanted in the patient, and wherein the pulse system is linked to the controller via a direct link or an indirect link such that the controller can direct the pulse system to activate and/or deactivate the electrodes independently.
6. The system of claim 1, further comprising a sensing device configured to be attached to a sensing location of the patient, the sensing device generating response signals defining the feedback input into the controller; and wherein the computer operable medium contains instructions that evaluate the response signals from the sensing device.
7. The system of claim 6 wherein the sensing device comprises a sense electrode configured to be attached to the patient at a sense location to sense a response to the stimulus applied to the therapy electrodes.
8. The system of claim 6 wherein the sensing device comprises a sense electrode configured to be attached to the patient at a sense location and an EMG unit coupled to the sense electrode.
9. The system of claim 6 wherein the sensing device comprises a functional MRI device that detects locations of neural-activity in the brain.
10. The system of claim 6 wherein the computer operable medium of the controller comprises a computer readable medium containing instructions causing the controller to perform the following method:
applying an electrical stimulus having a plurality of stimulus parameters to a selected configuration of the therapy electrodes;
sensing a response to the applied electrical stimulus using the sensing device;
determining whether the response is within a desired range or an improvement over a previous sensed response from a different electrical stimulus and/or a different configuration of therapy electrodes;
selecting an alternate configuration of the therapy electrodes and/or an alternate electrical stimulus;
repeating the applying, sensing, determining and selecting procedures using the alternate configuration of the therapy electrodes and/or the alternate electrical stimulus; and
choosing a configuration of therapy electrodes and/or an electrical stimulus corresponding to a sensed response that is within a desired range and/or is an improvement compared to other sensed responses.
11. The system of claim 6 wherein the computer operable medium of the controller comprises a computer readable medium containing instructions causing the controller to perform the following method:
sending a command signal from the controller to the pulse system;
delivering an electrical pulse from the pulse system to a configuration of the therapy electrodes;
sensing a response to the electrical pulse using the sensing device;
receiving a response signal from the sensing device at the controller;
in the controller, determining whether the signal is within a desired range or an improvement over a previous response signal from another electrical pulse and/or another configuration of the therapy electrodes, and selecting an alternate configuration of the therapy electrodes and/or an alternate electrical pulse;
repeating the sending, delivering, sensing, receiving, and determining procedures using the alternate configuration of therapy electrodes and/or the alternate electrical pulse; and
in the controller, identifying an effective pulse therapy electrode configuration and/or electrical pulse; and
storing the effective therapy electrode configuration and/or electrical parameter in a memory of the controller.
12. The system of claim 6 wherein the computer operable medium of the controller comprises a computer readable medium containing instructions causing the controller to perform the following method:
installing the electrode array at a therapy site of a patient;
installing the sensing device at a sense location of the patient;
selecting a setup configuration of the therapy electrodes and a control stimulus of electrical parameters;
applying the control stimulus to the therapy electrodes;
sensing a response in the patient with the sensing device and generating a response signal;
in the controller, evaluating the response signal by comparing the response signal with at least one of a desired response signal and/or an antecedent response signal sensed by the sensing device that have been stored in a memory of the controller;
in the controller, automatically choosing an alternate configuration of therapy electrodes according to the evaluation of the response signal with the desired response signal and/or the antecedent response signal;
reapplying the control stimulus to the alternate configuration of therapy electrodes and sensing a response signal using the sensing device; and
repeating the evaluating, choosing and reapplying procedures until the response signal is within a desired range and/or a desired number of therapy electrode configurations have been tested.
13. The system of claim 6 wherein the computer operable medium of the controller comprises a computer readable medium containing instructions causing the controller to perform the following method:
installing the electrode array at a therapy site of a patient;
installing the sensing device at a sense location of the patient;
applying an electrical stimulus having a plurality of stimulus parameters to a control configuration of therapy electrodes;
sensing a response in the patient with the sensing device and generating a response signal;
in the controller, evaluating the response signal by comparing the response signal with at least one of a desired response signal and/or an antecedent response signal sensed by the sensing device stored in a memory of the controller;
in the controller, automatically choosing an alternate set of stimulus parameters according to the evaluation of the response signal with the desired response signal and/or the antecedent response signal;
reapplying the alternate set of stimulus parameters to the setup configuration of therapy electrodes and sensing a response signal using the sensing device; and
repeating the evaluating, choosing and reapplying procedures until the response signal is within a desired range and/or a desired number of stimulus parameters have been tested.
14. The system of claim 6 wherein the computer operable medium of the controller comprises a computer readable medium containing instructions causing the controller to perform the following method:
selecting an initial set of stimulation parameters for an initial electrical stimulus;
applying the initial electrical stimulus to a configuration of the therapy electrodes at a target stimulation site of the patient;
sensing a response signal at a sensing site of the patient that corresponds to the initial electrical stimulus applied to the therapy electrodes;
independently adjusting a current intensity until a threshold electrical stimulus is identified, the threshold electrical stimulus having a threshold current intensity at which a response is first identified in a population of neurons of the target site; and
applying a sub-threshold electrical stimulus to the configuration of therapy electrodes, the sub-threshold electrical stimulus having a current intensity less than the current intensity of the threshold electrical stimulus.
15. In a computer, a method of automatically determining a favorable neuro-stimulation program for a patient, comprising:
applying an electrical stimulus having a plurality of stimulus parameters to a selected configuration of the therapy electrodes that have been installed at a target therapy site of a patient;
sensing a response to the applied electrical stimulus at a sensing device that has been installed at a sense location of the patient;
determining whether the response is within a desired range or an improvement over a previous sensed response from a different electrical stimulus and/or a different configuration of therapy electrodes;
selecting an alternate configuration of therapy electrodes and/or an alternate electrical stimulus;
repeating the applying, sensing, determining and selecting procedures using the alternate configuration of therapy electrodes and/or the alternate electrical stimulus; and
choosing a configuration of therapy electrodes and/or an electrical stimulus corresponding to a sensed response that is within a desired range and/or provides a better result compared to other sensed responses.
16. The method of claim 15 wherein the selecting procedure comprises computing an alternate stimulus parameter while maintaining a constant electrode configuration, and wherein computing the alternate stimulus parameter comprises correlating a plurality of different stimuli applied to the constant electrode configuration with corresponding sensed responses to determine a stimulus/response trend and estimating a new stimulus parameter that is expected to improve the efficacy according to the stimulus/response trend.
17. The method of claim 15 wherein the selecting procedure comprises computing an alternate electrode configuration while maintaining constant stimulus parameters, and wherein computing the alternate electrode configuration comprises correlating a plurality of sensed responses with corresponding electrode configurations to which the constant stimulus parameters were applied to determine an electrode-configuration/response trend and estimating a new electrode configuration that is expected to improve the efficacy according to the electrode-configuration/response trend.
18. The method of claim 15 wherein the selecting procedure comprises increasing a stimulus parameter when a stimulus/response trend indicates that an increase in the stimulus parameter improves the efficacy of the stimulus.
19. The method of claim 15 wherein the selecting procedure comprises decreasing a stimulus parameter when a stimulus/response trend indicates that a decrease in the stimulus parameter improves the efficacy of the stimulus.
20. The method of claim 15 wherein the applying, sensing, determining, selecting, repeating and choosing procedures are repeated on the same patient within a period not greater than one week.
21. The method of claim 15 wherein the applying, sensing, determining, selecting, repeating and choosing procedures are repeated on the same patient on consecutive days.
22. The method of claim 15 wherein the applying, sensing, determining and selecting procedures are completed in a time period not greater than approximately 300 seconds.
23. The method of claim 15 wherein two iterations of the applying, sensing, determining and selecting procedures are repeated in a time period not greater than approximately 90 seconds.
24. The method of claim 15 wherein two iterations of the applying, sensing, determining and selecting procedures are repeated in a time period not greater than approximately 180 seconds.
25. The method of claim 15 wherein two iterations of the applying, sensing, determining and selecting procedures are repeated in a time period of approximately 20-90 seconds.
26. The method of claim 15 wherein a single iteration of the applying, sensing, determining and selecting procedures is completed in a time period not greater than approximately 45 seconds.
27. The method of claim 15 wherein a single iteration of the applying, sensing, determining and selecting procedures is completed in a time period of approximately 10-30 seconds.
28. The method of claim 15 wherein the sensing procedure comprises attaching EMG sensors to a sense site of the patient, detecting peripheral responses to the stimuli applied to the electrodes, and automatically sending the detected peripheral responses to the controller.
29. The method of claim 15 wherein the sensing procedure comprises detecting data related to neural activity using a functional MRI and automatically sending the data to the controller.
30. The method of claim 15 wherein the data comprises coordinates of neural activity relative to the therapy electrodes.
31. The method of claim 15 wherein the data comprises intensity levels of neural activity.
32. In a computer, a method of automatically determining a favorable a neuro-stimulation program for a patient, comprising:
sending a command signal from a controller to a pulse system operatively coupled to the controller;
delivering an electrical pulse from the pulse system to a configuration of therapy electrodes in a therapy electrode array installed at a target stimulation site of a patient;
sensing a response to the electrical pulse at a sensing device installed at a sense location of the patient;
receiving a response signal from the sensing device at the controller;
in the controller, determining whether the signal is within a desired range or an improvement over a previous response signal from another electrical pulse and/or another configuration of therapy electrodes, and selecting an alternate configuration of therapy electrodes and/or an alternate electrical pulse;
repeating the sending, delivering, sensing, receiving, and determining procedures using the alternate configuration of therapy electrodes and/or the alternate electrical pulse; and
in the controller, identifying an effective pulse therapy electrode configuration and/or electrical pulse; and
storing the effective therapy electrode configuration and/or electrical pulse in a memory of the controller.
33. The method of claim 32 wherein the selecting procedure comprises computing an alternate stimulus parameter while maintaining a constant electrode configuration, and wherein computing the alternate stimulus parameter comprises correlating a plurality of different stimuli applied to the constant electrode configuration with corresponding sensed responses to determine a stimulus/response trend and estimating a new stimulus parameter that is expected to improve the efficacy according to the stimulus/response trend.
34. The method of claim 32 wherein the selecting procedure comprises computing an alternate electrode configuration while maintaining constant stimulus parameters, and wherein computing the alternate electrode configuration comprises correlating a plurality of sensed responses with corresponding electrode configurations to which the constant stimulus parameters were applied to determine an electrode-configuration/response trend and estimating a new electrode configuration that is expected to improve the efficacy according to the electrode-configuration/response trend.
35. The method of claim 32 wherein the selecting procedure comprises increasing a stimulus parameter when a stimulus/response trend indicates that an increase in the stimulus parameter improves the efficacy of the stimulus.
36. The method of claim 32 wherein the selecting procedure comprises decreasing a stimulus parameter when a stimulus/response trend indicates that a decrease in the stimulus parameter improves the efficacy of the stimulus.
37. The method of claim 32 wherein two iterations of the applying, sensing, determining and selecting procedures are repeated in a time period not greater than approximately 90 seconds.
38. The method of claim 32 wherein two iterations of the applying, sensing, determining and selecting procedures are completed in a time period not greater than approximately 180 seconds.
39. The method of claim 32 wherein the sensing procedure comprises attaching EMG sensors to a sense site of the patient, detecting peripheral responses to the stimuli applied to the electrodes, and automatically sending the detected peripheral responses to the controller.
40. The method of claim 32 wherein the sensing procedure comprises detecting data related to neural activity using a functional MRI and automatically sending the data to the controller.
41. A method of automatically determining a favorable neuro-stimulation program for a patient, comprising:
installing an electrode array having a plurality of therapy electrodes at a therapy site of a patient;
installing a sensing device at a sense location of the patient;
selecting a setup configuration of therapy electrodes and a control stimulus of electrical parameters;
applying the control stimulus to the therapy electrodes;
sensing a response in the patient with the sensing device and generating a response signal;
in the controller, evaluating the response signal by comparing the response signal with at least one of a desired response signal and/or an antecedent response signal sensed by the sensing device that have been stored in a memory of the controller;
in the controller, automatically choosing an alternate configuration of therapy electrodes according to the evaluation of the response signal with the desired response signal and/or the antecedent response signal;
reapplying the control stimulus to the alternate configuration of therapy electrodes and sensing a response signal using the sensing device; and
repeating the evaluating, choosing and reapplying procedures until the response signal is within a desired range and/or a desired number of therapy electrode configurations have been tested.
42. A method of automatically determining a favorable neuro-stimulation program for a patient, comprising:
installing an electrode array having a plurality of therapy electrodes at a therapy site of a patient;
installing a sensing device at a sense location of the patient;
applying an electrical stimulus having a plurality of stimulus parameters to a control configuration of therapy electrodes;
sensing a response in the patient with the sensing device and generating a response signal;
in the controller, evaluating the response signal by comparing the response signal with at least one of a desired response signal and/or an antecedent response signal sensed by the sensing device stored in a memory of the controller;
in the controller, adjusting at least one of the stimulus parameters according to the evaluation of the response signal with the desired response signal and/or the antecedent response signal;
reapplying the adjusted stimulus parameters to the setup configuration of therapy electrodes and sensing a response signal using the sensing device; and
repeating the evaluating, choosing and reapplying procedures until the response signal is within a desired range and/or a desired number of stimulus parameters have been tested.
43. A method of automatically determining a favorable sub-threshold neuro-stimulation program for a patient, comprising:
selecting a set of stimulation parameters for an electrical stimulus;
applying the electrical stimulus to a configuration of therapy electrodes at a target stimulation site of the patient;
sensing a response signal at a sensing site of the patient that corresponds to the electrical stimulus applied to the therapy electrodes;
independently adjusting a current intensity until a threshold electrical stimulus is identified, the threshold electrical stimulus having a threshold current intensity at which a response is first identified in a population of neurons of the target site; and
applying a sub-threshold electrical stimulus to the configuration of therapy electrodes, the sub-threshold electrical stimulus having a current intensity less than the current intensity of the threshold electrical stimulus.
44. The method of claim 43 wherein applying a sub-threshold stimulus comprises applying a sub-threshold current intensity of approximately 40-99% of the threshold current intensity.
45. The method of claim 43 wherein applying a sub-threshold stimulus comprises applying a sub-threshold current intensity of approximately 60-80% of the threshold current intensity.
46. The method of claim 43 wherein applying a sub-threshold stimulus comprises applying a sub-threshold current intensity of approximately 68-72% of the threshold current intensity.
47. The method of claim 43 wherein:
applying a sub-threshold stimulus comprises applying a sub-threshold current intensity of approximately 40-99% of the threshold current intensity; and
the method further comprises determining whether the application of the sub-threshold current intensity decreased a membrane activation threshold for a population of neurons subject to the sub-threshold stimulus.
48. The method of claim 43, further comprising decreasing the sub-threshold current intensity to a lower level and re-applying the decreased sub-threshold stimulus with the lower current intensity to the neurons, and further determining whether the application of the decreased sub-threshold current intensity further decreased the membrane activation threshold for the population of neurons.
49. The method of claim 43, further comprising repeating (a) decreasing the sub-threshold current intensity to a lower level, (b) re-applying the decreased sub-threshold stimulus with the lower current intensity to the neurons, and (c) further determining whether the application of the decreased sub-threshold current intensity further decreased the membrane activation threshold for the population of neurons until the membrane activation threshold does not decreased by a desired amount.
Descripción
    CROSS-REFERENCE TO RELATED APPLICATION(S)
  • [0001]
    This application is a continuation in part of U.S. application Ser. No. 09/802,808 filed Mar. 8, 2001, entitled “Methods and Apparatus for Effectuating a Lasting Change in a Neural-Function of a Patient,” which claims priority to U.S. Application No. 60/217,981 filed Jul. 13, 2000, which are herein incorporated in their entirety by reference.
  • TECHNICAL FIELD
  • [0002]
    The present disclosure is related to systems and methods for automatically optimizing the configuration of therapy electrodes and/or the stimulus parameters of the electrical or magnetic waveforms applied to a target stimulation site of a patient.
  • BACKGROUND
  • [0003]
    A wide variety of mental and physical processes are known to be controlled or influenced by neural activity in the central and peripheral nervous systems. For example, the neural-functions in some areas of the brain (i.e., the sensory or motor cortices) are organized according to physical or cognitive functions. There are also several other areas of the brain that appear to have distinct functions in most individuals. In the majority of people, for example, the areas of the occipital lobes relate to vision, the regions of the left interior frontal lobes relate to language, and the regions of the cerebral cortex appear to be consistently involved with conscious awareness, memory and intellect. The spinal cord is also organized so that specific regions of spinal cord are related to particular functions. Because of the location-specific functional organization of the central nervous system in which neurons at discreet locations are statistically likely to control particular mental or physical functions in normal individuals, stimulating neurons at selected locations of the central nervous system can be used to effectuate cognitive and/or motor functions throughout the body.
  • [0004]
    The neural activity in the central nervous system can be influenced by electrical and/or magnetic energy that is supplied from an external source outside of the body. Various neural functions can thus be promoted or disrupted by applying an electrical current to the cortex or other part of the central nervous system. As a result, the quest for treating or augmenting neural functions in the brain, spinal cord, or other parts of the body have led to research directed toward using electricity or magnetism to control these functions.
  • [0005]
    In several existing applications, the electrical or magnetic stimulation is provided by a neural-stimulator that has a plurality of therapy electrodes and a pulse system coupled to the therapy electrodes. The therapy electrodes can be implanted into the patient at a target site for stimulating the desired neurons. For example, one existing technique for masking pain in the lower extremities of a patient is to apply an electrical stimulus to a desired target stimulation site of the spinal cord. Although determining the general location of the target stimulation site may be relatively straight forward, identifying the specific configuration of electrodes for applying the stimulus will generally vary for specific patients.
  • [0006]
    The conventional procedure for optimizing the configuration of therapy electrodes involves several steps and relies on the subjective input from the patient. Conventional techniques generally involve rendering the patient unconscious, implanting an electrode array in the patient at the stimulation site, and then letting the patient regain consciousness. After the patient is conscious, the particular configuration of electrodes is optimized for that patient by selecting different combinations of the therapy electrodes and applying a constant electrical stimulus. The patient subjectively evaluates the effectiveness of each stimulus by indicating the degree to which the stimulus masks the pain. After testing the various configurations of therapy electrodes and deciding upon a desired electrode configuration according to the input of the patient, the patient is rendered unconscious for a second time to close the electrode array in the patient.
  • [0007]
    A similar procedure can be followed for determining the desired configuration of therapy electrodes for intra-cranial electrical stimulation. For example, a device for stimulating a region of the brain is disclosed by King in U.S. Pat. No. 5,713,922. King discloses a device for cortical surface stimulation having electrodes mounted on a paddle. The paddle can be implanted under the skull of the patient so that the electrodes are on the surface of the brain in a fixed position. King also discloses that the electrical pulses are generated by a pulse generator implanted in the patient remotely from the cranium (e.g., subclavicular implantation). The pulse generator is coupled to the electrodes by a cable that extends from the paddle, around the skull, and down the neck to the subclavicular location of the pulse generator.
  • [0008]
    King discloses implanting the electrodes in contact with the surface of the cortex to create paresthesia, which is a vibrating or buzzing sensation. More specifically, King discloses inducing paresthesia in large areas by placing the electrodes against particular regions of the brain and applying an electrical stimulus to the electrodes. This is similar to implanting therapy electrodes at the spinal cord of a patient for masking pain in the lower extremities of a patient, and thus King appears to require stimulation that exceeds the membrane activation threshold for a population of neurons at the electrodes (supra-threshold stimulation). King further discloses applying a stimulus to one set of electrodes, and then applying a stimulus to a separate configuration of electrodes to shift the location of the paresthesia.
  • [0009]
    One problem of the procedures for optimizing the configuration of therapy electrodes for either spinal or cortical stimulation is that existing systems and methods are expensive and time consuming. First, it is expensive to render the patient unconscious, implant the neural-stimulators in the patient, then wait for the patient to regain consciousness, then test various electrode configurations by asking the patient to subjectively estimate the degree to which the particular stimulus masks the pain, and then finally render the patient unconscious again to complete the implantation. Second, it can be a reasonably high risk operation because the patient is placed under general anesthesia at two separate stages of the process. It will be appreciated that this is an extremely long process that requires highly skilled doctors and personnel to attend to the patient for a significant period of time. Moreover, the patient occupies costly operating rooms and utilizes expensive equipment throughout the process. Third, relying on the subjective response from the patient may not provide accurate data for evaluating minor variances in the results. Fourth, the patient may experience pain or discomfort because some configurations may provide high intensity stimulation that exceeds the sensory level of stimulation. Therefore, existing systems for determining a desired configuration of electrodes to apply a neural-stimulus to specific patients are expensive, time consuming, potentially painful, and may not determine the most effective electrode configuration.
  • [0010]
    Another drawback of configuring the therapy electrodes using existing systems and methods is that the procedures are not effective for on-going use. This is because the patient's condition changes continually. For example, the location of the pain or the sensation typically shifts over time such that the optimal configuration of the electrodes at one point of the therapy may not mask the pain after a period of time. A large number of patients accordingly terminate electrical therapies for paresthesia within one year because of such a shift in the location of the pain/sensation. Therefore, although electrical stimulation for masking pain, inducing or enhancing plasticity, and other reasons appears to be very promising, it has not yet gained wide acceptance because of the drawbacks of configuring the therapy electrodes to apply an effective stimulus to different patients over a long period of time.
  • [0011]
    Additionally, it is also difficult to optimize the parameters of the electrical or magnetic stimulus. For example, even when a desired configuration of therapy electrodes is used, different waveforms can produce different results in each patient. Determining the stimulus parameters of the waveform can be even more time consuming than determining the desirable configuration of therapy electrodes because it involves testing a large number of independent variables. In a biphasic pulse train, for example, the stimulus parameters can include (a) the intensity of the electrical current, (b) the time of the stimulus of the first phase, (c) the time of the stimulus of the second phase, (d) the total time of the stimulus pulse, (e) the frequency of the stimulus pulse, (f) the pulse duty cycle, (g) the burst time of the stimulus, (h) the burst repetition rate of the stimulus, and (i) additional variables. Because of the large number of stimulus parameters, a particular waveform for the stimulus is typically selected for a given treatment for all patients such that the parameters for stimulus itself are not optimized.
  • [0012]
    In light of the several drawbacks for existing techniques of applying electrical or magnetic neural-stimulation to produce desired results, there is a significant need to enhance the procedures for applying such stimulus to individual patients. For example, it would be desirable to have more cost effective and less time consuming procedures for determining an effective configuration of therapy electrodes and stimulus parameters. Additionally, it would be desirable to update the electrode configuration and stimulus parameters in each individual patient without surgically operating on the patient to compensate for shifts in the target stimulation site.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • [0013]
    FIG. 1 is a schematic illustration of a system for automatically optimizing the configuration of the electrodes and/or the stimulus parameters in accordance with an embodiment of the invention.
  • [0014]
    FIG. 2 is a flow diagram illustrating a method for automatically optimizing the configuration of electrodes and/or the stimulus parameters in accordance with one embodiment of the invention.
  • [0015]
    FIG. 3 is a flow diagram of an embodiment of a method for optimizing the configuration of therapy electrodes that can be used in the method of FIG. 2 in accordance with an embodiment of the invention.
  • [0016]
    FIGS. 4A-4F illustrate various examples of using the system of FIG. 1 to optimize the configuration of the electrodes in accordance with an embodiment of the methods of FIGS. 2 and 3.
  • [0017]
    FIG. 5 is a flow diagram of a method for optimizing the stimulus parameters that can be used in the method of FIG. 2 in accordance with an embodiment of the invention.
  • [0018]
    FIG. 6 is a diagram illustrating an example of several stimulus parameters that can be optimized using an embodiment of the method of FIG. 5.
  • [0019]
    FIG. 7 is a flow diagram of a method for optimizing the electrode configuration and/or stimulus parameters for inducing and/or enhancing neural-plasticity using sub-threshold stimulation in accordance with an embodiment of the invention.
  • DETAILED DESCRIPTION
  • [0020]
    The following disclosure describes several methods and apparatus for automatically determining the configuration of therapy electrodes and/or the parameters for the stimulus to treat or otherwise effectuate a change in neural-functions of a patient. Several embodiments of methods in accordance with the invention are practiced using a computer to automatically implement such processes, but it is not necessary to use a computer in all of the embodiments. The specific details of certain embodiments of the invention are set forth in the following description and in FIGS. 1-7 to provide a thorough understanding of these embodiments to a person of ordinary skill in the art. More specifically, several embodiments of a system in accordance with the invention are described with reference to FIG. 1, and then several embodiments of methods for determining a desired configuration of therapy electrodes and/or stimulus parameters are described with reference to FIGS. 2-7. A person skilled in the art will understand that the present invention may have additional embodiments, or that the invention can be practiced without several of the details described below.
  • [0000]
    A. Systems for Automatically Optimizing Therapy Electrode Configurations and/or Stimulus Parameters
  • [0021]
    FIG. 1 illustrates an embodiment of a system for providing neuro-stimulation to a patient that can automatically optimize (a) the configuration of therapy electrodes, (b) the waveform parameters for the electrical stimulus, and/or (c) additional stimulation parameters. In this embodiment, the system 100 comprises an electrode array 110, a stimulus unit 120 operatively coupled to the electrode array 110, and at least one sensing device 180 operatively coupled to the stimulus unit 120. The electrode array 110 and the sensing unit 180 can be operatively coupled to the stimulus unit 120 by a direct connection (e.g., wires, cables, or fiber optical lines) or an indirect connection (e.g., RF energy, magnetic energy, infrared, etc.).
  • [0022]
    The electrode array 110 can include a support member 112 and a plurality of electrodes 114 that are carried by the support member 112. The electrode array 110 is generally configured to be implanted into a patient P for cortical stimulation, deep brain stimulation, spinal cord stimulation, cardiac stimulation, or stimulation of other parts of the body. For example, the electrode array 110 can be a cortical neural-stimulation device, such as one of the devices described in U.S. application Ser. No. 09/802,808 incorporated by reference above. The electrode array 110 can alternatively be a grid having a plurality of discreet electrodes 114 arranged in an X-Y coordinate system or another type of coordinate system. The therapy electrodes 114 can be independently coupled to the stimulus unit 120 by a link 116. In one embodiment, the link 116 is a wire or another type of conductive line, but in alternate embodiments the link 116 can be an indirect link (e.g., infrared, magnetic or RF energy). The link 116 can accordingly be a direct connection or an indirect connection to operatively couple the therapy electrodes 114 to the stimulus unit 120. It will be appreciated that many of the electrode arrays can be implanted at the spinal cord for spinal cord stimulation.
  • [0023]
    The stimulus unit 120 can include a controller 130 with a processor, a memory, and a programmable computer medium. The controller 130, for example, can be a computer and the programmable computer medium can be software loaded into the memory of the computer and/or hardware that performs the processes described below. The stimulus unit 120 can further include a pulse system 140, a converter 150, and a plurality of controls/indicators 160. The pulse system 140 can generate and send energy pulses to the electrode array, and the converter 150 can receive signals from the sensing device 180. The pulse system 140 and the converter 150 are both operatively coupled to the controller 130. The controls and indicators 160 can include a computer display, an input/output device (e.g., a keyboard, touch sensitive screen, etc.), or other types of devices commonly used to enter commands or receive output from computers.
  • [0024]
    The electrode array 110 and the pulse system 140 can be integrated into a single stimulation apparatus that can be implanted into the patient, as described in U.S. application Ser. No. 09/082,808. One example of an integrated pulse system 140 and electrode array 110 is configured to be implanted into the skull of the patient so that the electrodes contact the pia matter of the cortex. Such a device can have an internal power source that can be implanted into the patient and/or an external power source coupled to the pulse system via electromagnetic coupling or a direct connection. In alternate embodiments, the pulse system 140 is an external unit that is not implanted into the patient. The external pulse unit 140 can provide the electrical stimulus to the therapy electrodes 114 using RF energy, electromagnetism, or wire terminals exposed on the scalp of the patient P.
  • [0025]
    The sensing device 180 can be an electrode that produces an analog signal, and the converter 150 can convert the analog signal to a digital signal for processing by the controller 130. The sensing device 180 can be an implantable electrode that can be implanted at a number of different locations according to the desired response of the stimulus applied to the therapy electrodes 114. In alternate embodiments, the sensing device 180 can be an imaging device (e.g., an fMRI apparatus), an ultrasound apparatus, an EEG, a device that detects somatosensory evoked potentials, or another suitable apparatus for determining a response in the patient P to a stimulus applied to the therapy electrodes 114. The sensing device can alternatively detect behavioral responses. In an alternate embodiment, the sensing device 180 can produce a digital output and be coupled directly to the controller 130. Therefore, the converter 150 may only be used in some of the embodiments of the system 100.
  • [0026]
    The system 100 can automatically test the efficacy of various electrode configurations and stimulus parameters either with or without subjective input from the patient. In operation, the controller 130 sends command signals to the pulse system 140 defining the configuration of active electrodes and the waveform parameters for the stimulus. The pulse system 140 generates and sends a single pulse or pulse train to the active therapy electrodes in accordance with the command signals, and the sensing device 180 senses the neural responses, motor responses, or other types of responses to the stimulus. The sensing device 180 also sends signals corresponding to the magnitude of the responses to the controller 130, which compares the responses to previous responses and/or empirical responses for the type of therapy stored in the memory of the controller. The controller 130 then adjusts the configuration of active therapy electrodes and/or the waveform parameters of the stimulus to optimize the therapy for the particular patient. Several methods for using embodiments of the system 100 for supra- and sub-threshold neural-stimulation therapies are described below.
  • [0000]
    B. Methods of Optimizing Electrode Configurations and Stimulus Parameters for Neuro-Stimulation
  • [0027]
    FIGS. 2-7 illustrate several embodiments of methods in accordance with the invention that can be practiced using the stimulator system 100 described above. FIG. 2, for example, is a flow diagram illustrating an optimization process 200 that can be executed, at least in part, in a computer for automatically optimizing the configuration of therapy electrodes and/or the waveform parameters for the stimulus. The optimization process 200 generally starts after the therapy electrode array has been installed at a target stimulation site using surgical techniques known in the art and a sensing device has been positioned to sense a response to the electrical stimulus applied to the therapy electrodes.
  • [0028]
    After the therapy electrode array has been installed and the sensing device is ready to sense a response in the patient, the optimization process 200 begins with a setup procedure 210 in which a setup configuration of therapy electrodes and the waveform parameters for a control stimulus are selected. The controller can select the setup configuration for the electrodes and the control stimulus by retrieving predetermined setup values stored in a setup database in the memory of the controller. The setup database can contain at least one setup configuration for the therapy electrodes and at least one set of waveform parameters for the control stimulus. In several embodiments, a plurality of different setup configurations for the electrodes and the stimulus parameters can be stored in a database so that the system 100 can be used for many different types of neural therapies and procedures. An alternate embodiment can involve manually inputting the setup configuration for the electrodes and the waveform parameters for the control stimulus either in lieu of or in addition to having the controller retrieve setup data from memory. A practitioner, for example, can select the setup data from pull-down menus provided by the system 100 or manually key in the data.
  • [0029]
    The setup configurations for the therapy electrodes and the waveform parameters for control stimuli can be determined by manually performing optimization procedures on test groups of patients for each type of therapy. The optimal setups can be correlated with the particular therapy (e.g., enhancing neural plasticity in the cortex, masking pain, etc.), the particular target site, and the patient factors. For example, a first electrode configuration and control stimulus can be determined for sub-threshold cortical neural stimulation to restore functionality of a limb that was affected by a stroke or other type of brain damage; a second electrode configuration and control stimulus can be determined for cortical neural stimulation to enhance learning capabilities; a third electrode configuration and control stimulus can be determined for spinal stimulation to mask pain; and a fourth electrode configuration and control stimulus can be determined for sub- or supra-threshold stimulation applied to the cortex. It will be appreciated that many additional electrode configurations and stimulus parameters can be determined for other types of therapies such that the foregoing is not exhaustive of the various types of setup configurations.
  • [0030]
    Referring again to FIG. 2, the optimization process 200 continues with a stimulating procedure 220 and then a sensing procedure 230. The stimulating procedure 220 involves applying an electrical stimulus to a configuration of the therapy electrodes. Several iterations of the stimulation procedure 220 are generally performed several times at different stages throughout the optimization process 200, and the configuration of the electrodes and/or the stimulus parameters can be changed at each iteration of the stimulation procedure 220. For example, the initial iteration of the stimulating procedure 220 can involve applying the control stimulus to the setup configuration of therapy electrodes. Subsequent iterations of the stimulation procedure 220 can involve applying (a) the control stimulus to an alternate configuration of therapy electrodes; (b) an alternate stimulus with a different waveform to the setup electrode configuration; and/or (c) alternate stimuli with different waveforms to alternate electrode configurations. As explained above with reference to FIG. 1, the controller carries out the stimulation procedure 220 by sending command signals to the pulse system, which in turn generates and transmits energy having the parameters for the stimulus to the selected configuration of active therapy electrodes.
  • [0031]
    The sensing procedure 230 is generally performed after each iteration of the stimulation procedure 220. The sensing procedure 230 involves monitoring a location in the patient for a response to the stimulus applied in the stimulation procedure 220. The location for sensing the response and the particular type of response that is measured varies according to the particular type of therapy and other factors. In general, the physiologic outcome that the response measures can be categorized into three general areas: (1) cortical; (2) peripheral; and (3) functional. The types of measurements for monitoring cortical physiologic outcomes include: (a) action potential generation of the neurons; (b) excitability changes of the neurons measured waveform characteristics of EEG or field potentials within the cortex; (c) blood flow (e.g., doppler measurements); (d) thermal changes; (e) pulse oxymetry; (f) chemical metabolites; and (g) imaging techniques (e.g., functional MRI, MR spectroscopy, diffusion MRI, PET, CT, etc.). The types of measurements for monitoring peripheral physiologic outcomes include: (a) EMG (surface, percutaneous, or implanted); (b) external potentiometer or other forms of physiologic input; and (c) motion detectors (e.g., accelerometers). The types of measurements for monitoring functional physiologic outcomes include: (a) force/strength tests; (b) dexterity tests; (c) speed/reflex tests; and (d) performing complex tasks.
  • [0032]
    Several types of measurements that monitor the physiologic outcomes can be automated so that they generate signals which can be processed by the controller either with or without subjective input from the patient. In the case of EMG measurements for sensing peripheral responses to the applied stimulus, the electrical signals from the EMG sensors are automatically received and processed by the controller. In other applications, the data sensed by functional MRI, blood flow monitors, thermal monitors, pulse oxymeters, PET, MR spectroscopy, accelerometers, etc. can be digitized and process by the controller in a similar manner. In this manner, the stimulating procedure 220 and the sensing procedure 230 can be automated using a controller with the appropriate hardware and/or software.
  • [0033]
    The optimization process 200 also includes performing an evaluation procedure 240 after one or more iterations of the stimulating procedure 220 and the sensing procedure 230. The evaluation procedure 240 can involve a determination routine 242 in which a sensed response from the sensing procedure 230 is compared with a desired response range and/or other responses from previous iterations of the stimulation procedure 220 and the sensing procedure 230. Based upon whether the sensed response is within a desired range and/or shows an improvement compared to previous responses or target ranges, the controller can automatically test the effectiveness of other electrode configurations and stimulus parameters. For example, if the response is not within the desired response range, then the determination routine 242 directs the controller to select an alternate configuration for the therapy electrodes and/or alternate parameter for the stimulus. Alternatively, in one embodiment when the sensed response is within the desired response range, the determination routine 242 can direct the controller to proceed directly to a stop 270 and indicate that the configuration of therapy electrodes and the parameters for the stimulus have been optimized to treat the specific patient. In another embodiment when the sensed response is within the desired response range, the determination routine 242 directs the controller to select additional alternate configurations of the therapy electrodes and/or stimulus parameters to discover whether a more effective response can be achieved.
  • [0034]
    The process of selecting alternate therapy electrode configurations or stimulus parameters is performed by an analyzing procedure 260. In one embodiment, the analyzing procedure 260 is predicated upon the understanding that the electrode configuration and each of the stimulus parameters are independent variables that can be individually optimized while keeping the other variables constant. The analyzing procedure 260, therefore, can proceed by keeping one of the configuration of the therapy electrodes or the stimulus parameters constant and then progressively adjusting the other of these variables until the most effective result is obtained for the adjusted variable. For example, when the analyzing procedure 260 selects alternate stimulus parameters, it typically maintains the previous configuration of therapy electrodes and it adjusts only one of the stimulus parameters at a time. Conversely, the analyzing procedure 260 can keep the same stimulus parameters and select alternate configurations of therapy electrodes. The analyzing procedure 260 can select alternate inputs for the stimulus parameters and/or the electrode configurations by dynamically estimating new parameters based on projected response patterns for using empirical data developed for particular therapies and/or actual responses from previous stimuli applied to the patient. In one embodiment, the controller automatically analyzes the responses from previous stimulating procedures 220 to determine a pattern of improved or degraded effectiveness of the corresponding configurations of therapy electrodes and stimulus parameters that were applied in the iterations of the stimulation procedure 220. Based upon the pattern of responses, the analyzing routine 260 can then incrementally change one of the variables in a manner that concurs with a pattern showing improved responses or moves away from the pattern that shows deteriorated responses.
  • [0035]
    A basic example of the analyzing routine 260 involves optimizing the frequency of the electrical stimulus. As such, the configuration of electrodes and the other stimulus parameters remain constant for several iterations of the applying procedure 220. In one iteration a stimulus having a first frequency (e.g., 50 Hz) may produce marginal results as determined by the sensing and evaluation procedures 230 and 240. Without additional data, the analyzing procedure 260 selects a second stimulus with a second frequency either less or greater than the first frequency to get a general understanding of whether higher or lower frequencies produce more efficacious results. The controller, for example, can select a second frequency of 25 Hz. If a frequency of 25 Hz produces better results than 50 Hz, the controller can select still lower frequencies in the analyzing procedure 260; but, assuming for the sake of this example that a frequency of 25 Hz produces a worse result than 50 Hz, then the controller can select a third frequency higher than the second frequency (e.g., 100 Hz). If the higher third frequency (e.g., 100 Hz) produces a better result than the first frequency (e.g., 50 Hz), then the controller can select a still higher fourth frequency (e.g., 200 Hz) in a subsequent iteration of the procedure. The method 200 can continue in this manner by adjusting variables in a direction that produces better results until the results begin to deteriorate. At this point, it is expected that the optimal value for the variable is bracketed between the last value selected for the variable and the value of the iteration immediately preceding the penultimate iteration (i.e., the second-to-the-last iteration).
  • [0036]
    Several embodiments of the optimization procedure 200 that use the system 100 are expected to reduce the cost and time for optimizing the configuration of the therapy electrodes and the stimulus parameters. One feature of the optimizing method 200 is that the pulse system and the therapy electrodes can be an integrated unit that is implanted into the patient and controlled externally from the patient such that an external controller can adjust the variables (e.g., electrode configuration and/or stimulus parameters) without requiring opening the patient for access to the pulse system and/or the therapy electrodes. One benefit of this feature is that several different electrode configurations and stimulus parameters can be adjusted after implanting the electrode array, and the variables can also be tested rather quickly because the controller can automatically adjust the variables and apply the stimulus to the therapy electrodes in a manner that is expected to be much faster than manually adjusting the variables. Another benefit of this feature is that the patient need only be subject to a single application of an anesthetic because the patient can be closed up soon after implanting the electrode array and the test can be performed after closing the patient. As a result, several embodiments of the optimization procedure 200 are expected to reduce the time and costs for determining a desirable electrode configuration and stimulus parameters.
  • [0037]
    Several embodiments of the optimization procedure 200 are also expected to provide better results than relying solely on the subjective input of the patient. Another aspect of several embodiments of the system 100 is that the sensing device provides objective criteria that measures the response to the stimuli. This feature is expected to provide better accuracy in determining the effectiveness of the individual stimuli applied to the therapy electrodes. Moreover, the optimization procedure 200 can also expediently optimize the waveform parameters in addition to optimizing the configuration of therapy electrodes such that both the electrical components of the stimulus and the location(s) where the stimulus is applied are optimized for specific patients.
  • [0038]
    Another feature of several embodiments of the optimization method 200 using the system 100 is that they are expected to provide more effective therapies over a long period of time without additional surgical procedures. One feature that provides this benefit is that the pulse system and the electrode array can be implanted into the patient and controlled externally from the patient. As a result, when the effectiveness of the therapy degrades because the target site shifts or another variable changes, the sensing device 180 can be positioned relative to the patient and coupled to the controller to re-optimize the electrode configuration and/or the stimulus parameters without having to perform surgery on the patient. The system 100 can accordingly be operated using embodiments of the optimization procedure 200 at any time to compensate for shifts in the target location. Several embodiments of the optimization procedure 200 that use the system 100 are accordingly expected to provide more effective therapies for ongoing applications.
  • [0039]
    Still another benefit of several embodiments of the method 200 is that they are expected to be more comfortable for patients. One feature of the method 200 is that the sensing procedure can sense responses at levels that the patient cannot feel any sensations. As a result, is it not likely that the application of the stimulus will cause pain or discomfort.
  • [0040]
    FIG. 3 is a flow diagram illustrating one embodiment of a method for optimizing the configuration of therapy electrodes in accordance with the invention. In this embodiment, the method 300 can include a setup procedure 310 in which a setup configuration of therapy electrodes is selected. The setup configuration of therapy electrodes can be based upon historical data obtained from previous optimization procedures for specific patients or different types of therapies. After performing the setup procedure 310, the method 300 continues with a stimulating procedure 320 in which a control electrical stimulus is applied to the selected configuration of therapy electrodes. A response in the patient to the applied control stimulus is then sensed in a sensing procedure 330, which is generally performed after each iteration of the stimulating procedure 320. The stimulating procedure 320 and the sensing procedure 330 can be similar to those described above with reference to FIG. 2, except that the stimulating procedure 320 involves applying the same control stimulus for each iteration. The primary difference, therefore, is that the configuration of therapy electrodes can be changed for each iteration of the stimulating procedure 320.
  • [0041]
    The method 300 continues with an evaluation procedure 340 in which the sensed response from the sensing procedure 330 is compared with a predetermined range of desired responses and/or previous responses from the sensing procedure 330. The evaluation procedure 340 can have several different embodiments. The evaluation procedure 340, for example, can include a determination routine 342 that determines whether the sensed response is the optimized response. In one embodiment, the sense response is considered to be optimized when it is within a desired range of responses. The method 300 can accordingly proceed to stop when such a response is sensed. In another embodiment, the sensed response is considered to be optimized when it provides the best result of all possible configurations of electrodes. This embodiment generally involves applying the control stimulus to all possible configurations of electrodes before identifying the optimized electrode configuration. In still another embodiment, the sensed response is the optimized response when it provides the most effective result compared to other responses without testing all of the possible configurations of electrodes. This embodiment involves testing a number of electrode configurations, identifying a trend in electrode configurations that produce effective results, and determining if or when the trend no longer holds true. It will be appreciated that the evaluation procedure 340 can have several additional or different embodiments.
  • [0042]
    The method 300 can continue with an analyzing procedure 360 that selects an alternate therapy electrode configuration. The alternate therapy electrode configuration selected in the analyzing procedure 360 can be determined by comparing previous responses to other configurations of therapy electrodes to develop a pattern of improved responses and selecting a configuration that is expected to continue the trend. Alternatively, the analyzing procedure 360 can simply select another therapy electrode configuration that has not yet been tested. The method can also include a final selection procedure 365 that selects the optimized configuration of the therapy electrodes based upon the sensed responses. The process 300 can then terminate with a final stop procedure 370 in which the optimized electrode configuration is stored in memory, displayed to a practitioner, or otherwise presented for use.
  • [0043]
    FIGS. 4A-4L illustrate several examples of therapy electrode configurations that can be selected in the analyzing procedure 360 and then tested in the stimulating procedure 320, the sensing procedure 330, and the evaluation procedure 340. In these embodiments, a therapy electrode array 400 for use with the system 100 (FIG. 1) can include an implantable support member 410 and a plurality of electrodes 420 carried by the support member 410. The therapy electrodes 420 can be individual electrodes that are arranged in a grid array having M columns and N rows. The electrode array 400 can have several other arrangements of electrodes 420, such as concentric circles, elongated lines, or many other patterns. Each of the electrodes 420 can be independently coupled to a pulse system so that individual electrodes 420 can be activated or inactivated using the controller 130 (FIG. 1) and the pulse system 140 (FIG. 1). The electrode array 400 is typically implanted into the patient so that the electrodes 420 are placed generally over or proximate to a target location T for stimulation. In many embodiments, the target location T can be at the surface of the cortex, along the spinal cord, or within a deep brain region of a patient depending upon the particular treatment being applied to the patient.
  • [0044]
    FIGS. 4A and 4B illustrate two alternate embodiments of selecting therapy electrode configurations. Referring to FIG. 4A, a setup configuration of two active electrodes 420 a can be selected such that the electrodes are within the target location T. One of the active electrodes 420 a can be biased with a positive polarity and the other active electrode 420 a can be biased with a negative polarity. Referring to FIG. 4B, a subsequent iteration of the process can include selecting an alternate configuration of therapy electrodes in which the polarity of the active electrodes 420 a is switched. FIGS. 4C-4E illustrate alternate embodiments of selecting different configurations of therapy electrodes using the analyzing procedure 360 explained above with reference to FIG. 3. As can be seen from FIGS. 4C-4E, the active therapy electrodes 420 a can be inside and/or outside of the target location T FIG. 4C illustrates an embodiment in which all of the active electrodes 420 a are within the target location and adjacent to one another, and FIGS. 4D and 4E illustrate embodiments in which at least some of the active electrodes 420 a are outside of the target location T and one or more inactive electrodes 420 are between some of the active electrodes 420 a. It will be appreciated that the analyzing procedure 360 can select any configuration of therapy electrodes 420 in the M×N electrode array 400 such that any combination of electrodes 420 can be active electrodes.
  • [0045]
    FIG. 4F illustrates another aspect of selecting a desired configuration of therapy electrodes in which an original target location To (shown in broken lines) has changed to a current target location Tc. The shift from the original target location To to the current target location Tc can be caused by several generally unpredictable factors. The methods 200 and 300 can compensate for such a target location shift without additional surgery because the therapy electrodes can be optimized using an external control and indirect coupling with the pulse system and/or or the electrode array. Thus, the application of the stimulus can be changed as the target location of neural activity shifts to provide efficacious treatment over a long period of time.
  • [0046]
    FIGS. 4G and 4H illustrate different embodiments of therapy electrical configurations that can be selected in the analyzing procedure 360 in which several electrodes on opposite areas of the target location are activated with a common polarity. Referring to FIG. 4G, for example, this embodiment illustrates a series of active electrodes on opposite ends of the target location T One embodiment of this configuration applies a common polarity to a first set 420 a1 of active electrodes and an opposite polarity to a second set 420 a2 of active electrodes. Another embodiment can apply the same polarity to all of the active electrodes in both of the sets 420 a1 and 420 a2. FIG. 4H illustrates a related embodiment in which a number of electrodes on opposite sides of the target location T are active electrodes. The electrode configuration shown in FIG. 4H can also apply a common polarity to all of the active electrodes on each side of the target location T or all of the electrodes on both sides of the target location T.
  • [0047]
    FIGS. 4I and 4J illustrate additional embodiments of electrode configurations that can be selected in the analyzing procedure 360 and then tested in the stimulation procedure 320. FIG. 4I illustrates an embodiment in which a first set 420 a1 of active electrodes has a common polarity at one end of the target location T, and a second set 420 a2 of active electrodes is located at an opposite end of the target location T The polarity of the electrodes in the second set 420 a2 can be opposite or the same as those of the active electrodes in the first subset 420 a1. FIG. 4J illustrates a similar embodiment in which a first set 420 a1 of active electrodes is located within the target location T along one side, and a second set 420 a2 of active electrodes is located within a target location T along an opposite side. The electrodes in the first set 420 a1 can have one polarity, and the electrodes in the second set 420 a2 can have an opposite polarity.
  • [0048]
    FIGS. 4K and 4L illustrate additional embodiments of therapy electrode configurations that can be selected in the analyzing procedure 360 and then tested in the stimulation procedure 320. Referring to FIG. 4K, this embodiment illustrates a first set 420 a1 of active electrodes at one end of the target location T and a second set 420 a2 of active electrodes at an opposite end of the target location T. The active electrodes in the first set 420 a1 can have opposite polarities and similarly the active electrodes in the second set 420 a2 can have opposite polarities. The active electrodes in the first and second sets 420 a1 and 420 a2 can be located outside of the target location T as shown in FIG. 4K. FIG. 4L illustrates a related embodiment in which the active electrodes in the first set 420 a1 have opposite polarities, and the active electrodes in the second set 420 a2 have opposite polarities. The active electrodes in the first and second sets 420 a1 and 420 a2 shown in FIG. 4L are located within the boundaries of the target location T. It will be appreciated that the invention can have several additional embodiments in which the individual sets of electrodes can be inside, outside, inside and outside, and have different combinations of polarities.
  • [0049]
    Another aspect of the invention is optimizing the parameters for the electrical stimulus in addition to or in lieu of optimizing the configuration of therapy electrodes. FIG. 5 is a flow diagram of a method for optimizing the desired parameters for the electrical stimulus in accordance with an embodiment of the invention. In this embodiment, the method 500 can include a setup procedure 510 in which a therapy electrode configuration and the initial parameters for the electrical stimulus are selected. The configuration of therapy electrodes can be the optimized configuration from the method 300 explained above with reference to FIG. 3, or it can be another configuration input by a practitioner or retrieved from memory in the controller. The same configuration of therapy electrodes is generally maintained throughout the method 500. After performing the setup procedure 510, the method 500 continues with a first stimulating procedure 520 in which the electrical stimulus is applied to the selected configuration of therapy electrodes using the initial parameters of the electrical stimulus. A response in the patient to the initial electrical stimulus is sensed in a first sensing procedure 530. The procedures 510-530 accordingly provide a response to an initial electrical stimulus based upon the initial stimulus parameters to provide a baseline response.
  • [0050]
    The method 500 continues with an adjusting procedure 540 in which one of the stimulus parameters for the electrical stimulus is adjusted, and then a second stimulating procedure 550 in which the adjusted stimulus is applied to the therapy electrodes. A response to the adjusted stimulus is then determined using a second sensing procedure 560. The method 500 can repeat the procedures 540-560 several times for each of the parameters of the electrical stimulus to develop a plurality of responses for each parameter.
  • [0051]
    The method 500 can then continue with an evaluation procedure 570 in which the responses are evaluated to determine specific values for the stimulus parameters that provide an efficacious result. The evaluation procedure 570 can include a determination routine 572 that determines whether a parameter of the stimulus has been optimized. If the response for a parameter is not optimized, then the method can continue by repeating the procedures 540-560 for the parameters that are not within a desired range. However, if the response is optimized, then the determination routine 572 can continue to a final selection procedure 580 in which a set of electrical parameters that produce a desirable response are selected.
  • [0052]
    FIG. 6 is a graph illustrating some of the stimulus parameters that can be optimized using the method 500. A stimulus start time to defines the initial point at which an electrical or magnetic pulse is applied to the therapy electrodes. For a biphasic waveform, the parameters typically include a pulse width t1 for a first phase, a pulse width t2 for a second phase, and a stimulus pulse width t3 for a single biphasic pulse. The pulse can alternatively be a monophasic pulse. The parameters can also include a stimulus repetition rate 1/t4 corresponding to the frequency of the pulses, a stimulus pulse duty cycle equal to t3 divided by t4, a stimulus burst time t5 that defines the number of pulses in a pulse train, and/or a stimulus pulse repetition rate 1/t6 that defines the stimulus burst frequency. Another parameter of the electrical stimulus is the intensity of the current I1, for the first phase and the current intensity I2 for the second phase of each pulse. In another embodiment, a continuous pulse train can be used such that t5=t6.
  • [0053]
    In a typical application, one of the parameters is adjusted for each application of the stimulus while maintaining the other parameters constant to determine the affect that adjusting the one parameter has on the response in the patient. Each of the parameters are believed to be independent from one another, thus one of the parameters can be optimized by applying a number of different stimuli using different values for the parameter to determine whether increasing or decreasing the parameter enhances the efficacy of the stimulus. Once it is determined whether increasing or decreasing the parameter provides a better result, then the parameter can be further increased or decreased (whichever is more desirable) until the effectiveness of the stimulation degrades. The optimized value for a particular stimulus parameter can then be stored in memory, and then a different stimulus parameter can be optimized using a similar procedure for that parameter. As such, one or more of the stimulus parameters can be optimized using this procedure.
  • [0054]
    The embodiments of the methods 200, 300 and 500 described above can be used to optimize procedures for cortical stimulation, spinal stimulation, deep brain stimulation, and peripheral stimulation for a number of different applications. The spinal stimulation and certain aspects of the cortical stimulation can be used to mask pain, such as back pain, phantom limb pain experienced by amputees, or pain in the lower extremities. The deep brain stimulation can be optimized to treat movement disorders (e.g., Parkinson's disease, distonia, etc.), depression, or other functions related to deep brain neural activity. The methods can also be used to optimize therapies for cortical stimulation that enhance learning functions, restore motor functions (e.g., use of muscle groups affected by stroke or other trauma), and treating diseases or seizures (e.g., Alzheimer's, epilepsy, etc.). Many of the embodiments of the methods 200, 300 and 500 for masking pain involve applying supra-threshold activation stimuli to the therapy electrodes. On the other hand, several of the cortical neural-stimulation procedures that are not directed toward masking pain but rather seek to enhance existing functions (e.g., learning) or rehabilitate impaired functions (e.g., brain damage) use sub-threshold activation stimuli that do not exceed the membrane activation threshold of a population of neurons in the target stimulation site. Several embodiments of the methods 200, 300 and 500 that are directed more specifically toward sub-threshold optimization of the neural-stimulation procedures are described below with reference to FIG. 7.
  • [0000]
    C. Sub-Threshold Optimization Methods
  • [0055]
    FIG. 7 is a flow diagram illustrating an embodiment for optimizing a sub-threshold simulation therapy. Sub-threshold simulation involves training and/or recruiting neurons to perform a neural-function. The target location can be a site where neural-plasticity is occurring or is expected to occur. The present inventors believe that neurons become more likely to be able to carry out desired neural-functions for enhancing, repairing or restoring functionality after being stimulated electrically at a level below the membrane activation threshold for a significant population of neurons at the target site. The present inventors also believe that certain sub-threshold simulation lowers the threshold at which neurons are activated in response to physical or cognitive input to produce a lasting change in the membrane potential such that the neurons may eventually “fire” in response to motor or cognitive functions after termination of the stimulus. The optimization procedure for sub-threshold simulation accordingly seeks to select stimulus parameters that produce the desired neural-activity at the lowest level of stimulation.
  • [0056]
    Referring to the flow diagram of FIG. 7, this figure illustrates an embodiment of a method 700 including a setup procedure 710 in which the configuration of therapy electrodes and the parameters for the stimulus are selected. The therapy electrode configuration and the stimulus parameters can be determined by optimizing them as described above with reference to FIGS. 1-6. The method 700 then continues with an activation threshold determination procedure 720 that determines the intensity of the electrical current for the stimulus that causes a reaction in a population of the neurons at the target location to exceed the membrane activation threshold. In one embodiment, the threshold determination procedure 720 involves sensing responses in the patient that are related to changes in the membrane potential of the neurons. It is difficult to measure the actual membrane potential of a neuron, so the determination procedure 720 generally measures a tangible response that is a surrogate for the change in the membrane potential. One such surrogate measurement of changes in the membrane potential is the EMG response to the stimulus applied to the therapy electrodes. The threshold determination procedure 720 accordingly involves adjusting the stimulus parameters until the electrical current intensity just begins to produce an EMG response indicating that a significant population of neurons at the target location have just exceeded their membrane potential. After the EMG indicates a threshold electrical current, the method 700 includes a delaying period 730 in which the effects of the supra-threshold stimulus are allowed to “wash out” from the neurons.
  • [0057]
    The method 700 further includes a sub-threshold stimulation procedure involving a selecting procedure 740 in which the intensity of the electrical current is lowered to a “sub-threshold” level, and a stimulation procedure 750 in which the sub-threshold stimulus is applied to the configuration of therapy electrodes. The selecting procedure 740 can involve selecting an electrical current that is a percentage of the threshold electrical current identified in the threshold determination procedure 720. In one embodiment, the sub-threshold current intensity is initially selected to be from approximately 40%-99% of the threshold electrical current membrane. After the sub-threshold electrical current intensity has been applied to the electrode configuration in the stimulation procedure 750, a sensing procedure 760 determines whether the sub-threshold stimulus reduced the membrane activation threshold for a population of neurons.
  • [0058]
    The sensing procedure 760 can proceed in a manner similar to the activation threshold procedure 720 explained above by applying an electrical pulse having a sensing current intensity above the sub-threshold stimulus applied in the stimulating procedure 740 and below the initial threshold stimulus level that was measured in the threshold determining procedure 720. For example, if the threshold current for the threshold stimulus that produced the threshold activation was 10 mA and the sub-threshold current applied in the stimulating procedure 750 was 7 mA, then the sensing procedure 760 can start with a sensing current intensity of 7.5 mA and incrementally increase the sensing current intensity (e.g., by 0.5 mA increments). The sensing current is increased until the EMG measurements indicate that the membrane potential of a population of neurons has been exceeded. This is a ramp up procedure that works up from the sub-threshold current intensity applied in the stimulating procedure 750. An alternate embodiment is a ramp down procedure in which the sensing current intensity is initially set at a level near the threshold current intensity (e.g., 90-99%) and works down until a threshold activation is not detected. In either case, the sensing procedure 760 determines a secondary threshold current intensity corresponding to a change in the membrane threshold activation.
  • [0059]
    The method 700 then continues with an analyzing procedure 770 that determines whether the secondary current intensity is less than the initial threshold current intensity. If so, then the method 700 continues to identify that the stimulation is enhancing the plasticity of the neurons at stage 772, and then the method 700 either repeats procedures 740-760 with a lower sub-threshold electrical current intensity or it selects an optimized sub-threshold current intensity for use with the patient at stage 782. If the analyzing procedure 770 determines that the threshold activation of the neurons is not decreasing, then the method 700 proceeds to stage 774. In one embodiment in which a number of different electrical current intensities have reduced the activation threshold of the neurons, the method 700 continues from stage 774 to stage 782 to select the most effective sub-threshold current intensity that has been tested for use on the patient. In another embodiment in which the stimulus parameters applied to the therapy electrodes have not decreased the activation threshold, the method 700 can repeat procedures 740-770 to determine whether a different electrical current intensity can produce a lower activation threshold. In still another embodiment in which the activation threshold does not decrease after application of the stimulus, the method 700 can continue with stage 784 that involves adjusting the electrical configuration, the timing parameters of the electrical stimulation, and/or the target location of the electrodes. After stage 784, the method 700 can then proceed with repeating procedures 740-770 to determine whether the activation threshold can be lowered by applying the new stimulus parameters to the therapy electrodes in accordance with the changes that were made in stage 784.
  • [0060]
    From the foregoing, it will be appreciated that specific embodiments of the invention have been described herein for purposes of illustration, but that various modifications may be made without deviating from the spirit and scope of the invention. For example, the electrode arrays and sensing devices could be configured for use in cardiac applications to optimize implantable pacemakers or implantable defibrillators. It will be appreciated that the applications of the invention in the field of cardiology are embodiments of optimizing a peripheral stimulation treatment. Many aspects of the invention are also applicable to magnetic stimulation in addition to or in lieu of electrical stimulation. In magnetic applications, the parameters for the stimulation can be automatically set using the algorithms explained above for electrical stimulation; but, instead of selecting different configurations of a subcutaneous array of electrodes, the location and configuration of a magnetic transducer can be moved externally relative to the body. In still further applications of the inventions, many of the embodiments of the apparatus and methods can be particularly useful for optimizing spinal cord stimulation therapies and procedures. Accordingly, the invention is not limited except as by the appended claims.
Citas de patentes
Patente citada Fecha de presentación Fecha de publicación Solicitante Título
US4019518 *11 Ago 197526 Abr 1977Medtronic, Inc.Electrical stimulation system
US4390023 *30 Abr 198128 Jun 1983Medtronic, Inc.Patterned electrical tissue stimulator
US4532931 *29 Jun 19846 Ago 1985Cardiac Pacemakers, Inc.Pacemaker with adaptive sensing means for use with unipolar or bipolar leads
US4541432 *17 Dic 198217 Sep 1985Neurotronic LteeElectric nerve stimulator device
US5470846 *14 Ene 199428 Nov 1995Sandyk; ReuvenTreatment of neurological and mental disorders
US5540734 *28 Sep 199430 Jul 1996Zabara; JacobCranial nerve stimulation treatments using neurocybernetic prosthesis
US5674264 *17 Ene 19967 Oct 1997Cochlear Ltd.Feedback system to control electrode voltages in a cochlear stimulator and the like
US5713922 *25 Abr 19963 Feb 1998Medtronic, Inc.Techniques for adjusting the locus of excitation of neural tissue in the spinal cord or brain
US5938689 *1 May 199817 Ago 1999Neuropace, Inc.Electrode configuration for a brain neuropacemaker
US6038480 *17 Feb 199814 Mar 2000Medtronic, Inc.Living tissue stimulation and recording techniques with local control of active sites
US6094598 *25 Abr 199625 Jul 2000Medtronics, Inc.Method of treating movement disorders by brain stimulation and drug infusion
US6227203 *9 Sep 19988 May 2001Medtronic, Inc.Techniques for controlling abnormal involuntary movements by brain stimulation and drug infusion
US6263237 *14 Feb 200017 Jul 2001Medtronic, Inc.Techniques for treating anxiety disorders by brain stimulation and drug infusion
US6353762 *30 Abr 19995 Mar 2002Medtronic, Inc.Techniques for selective activation of neurons in the brain, spinal cord parenchyma or peripheral nerve
US6381496 *25 Sep 200030 Abr 2002Advanced Bionics CorporationParameter context switching for an implanted device
US6425852 *18 Ene 200030 Jul 2002Emory UniversityApparatus and method for transcranial magnetic brain stimulation, including the treatment of depression and the localization and characterization of speech arrest
US6473634 *22 Nov 200029 Oct 2002Koninklijke Philips Electronics N.V.Medical imaging at two temporal resolutions for tumor treatment planning
US6497699 *9 Ago 200024 Dic 2002The Research Foundation Of State University Of New YorkHybrid neuroprosthesis for the treatment of brain disorders
US6609030 *24 Feb 200019 Ago 2003Electrocore Techniques, LlcMethod of treating psychiatric diseases by neuromodulation within the dorsomedial thalamus
US6609031 *7 Jun 199619 Ago 2003Advanced Neuromodulation Systems, Inc.Multiprogrammable tissue stimulator and method
US6631295 *25 Sep 20017 Oct 2003University Of Iowa Research FoundationSystem and method for diagnosing and/or reducing tinnitus
US6632174 *6 Jul 200014 Oct 2003Cognifit Ltd (Naiot)Method and apparatus for testing and training cognitive ability
US6647296 *17 Ago 200111 Nov 2003Neuropace, Inc.Implantable apparatus for treating neurological disorders
US6819956 *11 Nov 200116 Nov 2004Dilorenzo Daniel J.Optimal method and apparatus for neural modulation for the treatment of neurological disease, particularly movement disorders
US6871098 *30 Oct 200122 Mar 2005Medtronic, Inc.Method for treating obsessive-compulsive disorder with electrical stimulation of the brain internal capsule
US7050856 *11 Ene 200223 May 2006Medtronic, Inc.Variation of neural-stimulation parameters
US7305268 *15 Oct 20014 Dic 2007Northstar Neurscience, Inc.Systems and methods for automatically optimizing stimulus parameters and electrode configurations for neuro-stimulators
US7346395 *18 Jun 200418 Mar 2008Advanced Neuromodulation Systems, Inc.Method of treating depression, mood disorders and anxiety disorders using neuromodulation
US20020058867 *15 Feb 200116 May 2002Breiter Hans C.Method and apparatus for measuring indices of brain activity during motivational and emotional function
US20020062143 *9 Nov 200123 May 2002Medtronic, Inc.Techniques for selective activation of neurons in the brain, spinal cord parenchyma or peripheral nerve
US20030028072 *17 Sep 20026 Feb 2003Neuropace, Inc.Low frequency magnetic neurostimulator for the treatment of neurological disorders
US20030097159 *16 Dic 200222 May 2003Schiff Nicholas D.Feedback mechanism for deep brain stimulation
US20030181954 *24 Dic 200225 Sep 2003Rezai Ali R.Modulation of the brain to affect psychiatric disorders
US20040092809 *28 Jul 200313 May 2004Neurion Inc.Methods for measurement and analysis of brain activity
US20050033379 *18 Jun 200410 Feb 2005Advanced Neuromodulation Systems, Inc.Method of treating depression, mood disorders and anxiety disorders using neuromodulation
US20060058856 *14 Sep 200416 Mar 2006Neuropace, Inc.Responsive therapy for psychiatric disorders
US20060212091 *1 Mar 200621 Sep 2006Functional Neuroscience Inc.Method of treating depression, mood disorders and anxiety disorders using neuromodulation
US20060241717 *19 Ago 200226 Oct 2006Whitehurst Todd KTreatment of movement disorders by extra dural motor cortex stimulation
US20060259094 *10 May 200616 Nov 2006Biophysical Mind Technologies, Ltd.Diagnosis, treatment, and research of brain disorders
US20070060974 *16 Dic 200515 Mar 2007Lozano Andres MCognitive function within a human brain
US20070088403 *19 Oct 200519 Abr 2007Allen WylerMethods and systems for establishing parameters for neural stimulation
US20070088404 *19 Oct 200519 Abr 2007Allen WylerMethods and systems for improving neural functioning, including cognitive functioning and neglect disorders
US20070179558 *30 Ene 20062 Ago 2007Gliner Bradford ESystems and methods for varying electromagnetic and adjunctive neural therapies
US20080039895 *6 Abr 200714 Feb 2008Northstar Neuroscience, Inc.Electromagnetic signal delivery for tissue affected by neuronal dysfunction, degradation, damage, and/or necrosis, and associated systems and methods
US20080045775 *22 Dic 200421 Feb 2008Andres M LozanoMethod and Apparatus for Affecting Neurologic Function and/or Treating Neurologic Dysfunction Through Timed Neural Stimulation
Citada por
Patente citante Fecha de presentación Fecha de publicación Solicitante Título
US76848662 Ago 200423 Mar 2010Advanced Neuromodulation Systems, Inc.Apparatus and methods for applying neural stimulation to a patient
US772977318 Oct 20061 Jun 2010Advanced Neuromodualation Systems, Inc.Neural stimulation and optical monitoring systems and methods
US780160127 Ene 200621 Sep 2010Cyberonics, Inc.Controlling neuromodulation using stimulus modalities
US780161822 Jun 200721 Sep 2010Neuropace, Inc.Auto adjusting system for brain tissue stimulator
US783130515 Oct 20029 Nov 2010Advanced Neuromodulation Systems, Inc.Neural stimulation system and method responsive to collateral neural activity
US786986727 Oct 200611 Ene 2011Cyberonics, Inc.Implantable neurostimulator with refractory stimulation
US786988528 Abr 200611 Ene 2011Cyberonics, IncThreshold optimization for tissue stimulation therapy
US796222028 Abr 200614 Jun 2011Cyberonics, Inc.Compensation reduction in tissue stimulation therapy
US797470127 Abr 20075 Jul 2011Cyberonics, Inc.Dosing limitation for an implantable medical device
US797470726 Ene 20075 Jul 2011Cyberonics, Inc.Electrode assembly with fibers for a medical device
US79837575 Jun 200819 Jul 2011Medtronic, Inc.Medical device configuration based on sensed brain signals
US799607924 Ene 20069 Ago 2011Cyberonics, Inc.Input response override for an implantable medical device
US80904468 Abr 20083 Ene 2012Advanced Neuromodulation Systems, Inc.Methods and systems for establishing neural stimulation parameters and providing neural stimulation
US812169425 Sep 200821 Feb 2012Medtronic, Inc.Therapy control based on a patient movement state
US815050829 Mar 20073 Abr 2012Catholic Healthcare WestVagus nerve stimulation method
US818046218 Abr 200615 May 2012Cyberonics, Inc.Heat dissipation for a lead assembly
US818520724 Jun 201122 May 2012Medtronic, Inc.Medical device configuration based on sensed brain signals
US820460325 Abr 200819 Jun 2012Cyberonics, Inc.Blocking exogenous action potentials by an implantable medical device
US821918829 Mar 200710 Jul 2012Catholic Healthcare WestSynchronization of vagus nerve stimulation with the cardiac cycle of a patient
US823902824 Abr 20097 Ago 2012Cyberonics, Inc.Use of cardiac parameters in methods and systems for treating a chronic medical condition
US826042625 Ene 20084 Sep 2012Cyberonics, Inc.Method, apparatus and system for bipolar charge utilization during stimulation by an implantable medical device
US828050510 Mar 20092 Oct 2012Catholic Healthcare WestVagus nerve stimulation method
US829059625 Sep 200816 Oct 2012Medtronic, Inc.Therapy program selection based on patient state
US829594623 May 201123 Oct 2012Cyberonics, Inc.Electrode assembly with fibers for a medical device
US83374041 Oct 201025 Dic 2012Flint Hills Scientific, LlcDetecting, quantifying, and/or classifying seizures using multimodal data
US838031416 Oct 200719 Feb 2013Medtronic, Inc.Patient directed therapy control
US838266729 Abr 201126 Feb 2013Flint Hills Scientific, LlcDetecting, quantifying, and/or classifying seizures using multimodal data
US84123354 Jun 20122 Abr 2013Advanced Neuromodulation Systems, Inc.Systems and methods for automatically optimizing stimulus parameters and electrode configurations for neuro-stimulators
US841734424 Oct 20089 Abr 2013Cyberonics, Inc.Dynamic cranial nerve stimulation based on brain state determination from cardiac data
US845238720 Sep 201028 May 2013Flint Hills Scientific, LlcDetecting or validating a detection of a state change from a template of heart rate derivative shape or heart beat wave complex
US845774720 Oct 20084 Jun 2013Cyberonics, Inc.Neurostimulation with signal duration determined by a cardiac cycle
US847842012 Jul 20062 Jul 2013Cyberonics, Inc.Implantable medical device charge balance assessment
US847842823 Abr 20102 Jul 2013Cyberonics, Inc.Helical electrode for nerve stimulation
US84838367 Sep 20119 Jul 2013Greatbatch Ltd.Automated search to identify a location for electrical stimulation to treat a patient
US84838468 Abr 20109 Jul 2013Cyberonics, Inc.Multi-electrode assembly for an implantable medical device
US85543256 Ene 20128 Oct 2013Medtronic, Inc.Therapy control based on a patient movement state
US8560073 *22 Mar 201015 Oct 2013Flint Hills Scientific, LlcSystem and apparatus for automated quantitative assessment, optimization and logging of the effects of a therapy
US856253629 Abr 201022 Oct 2013Flint Hills Scientific, LlcAlgorithm for detecting a seizure from cardiac data
US856586725 Ene 200822 Oct 2013Cyberonics, Inc.Changeable electrode polarity stimulation by an implantable medical device
US857164316 Sep 201029 Oct 2013Flint Hills Scientific, LlcDetecting or validating a detection of a state change from a template of heart rate derivative shape or heart beat wave complex
US861530929 Mar 200724 Dic 2013Catholic Healthcare WestMicroburst electrical stimulation of cranial nerves for the treatment of medical conditions
US864164630 Jul 20104 Feb 2014Cyberonics, Inc.Seizure detection using coordinate data
US864987130 Abr 201011 Feb 2014Cyberonics, Inc.Validity test adaptive constraint modification for cardiac data used for detection of state changes
US866064913 Oct 200925 Feb 2014Starlab Barcelona S.L.Multi-site cranial stimulation method and system
US866066610 Mar 200925 Feb 2014Catholic Healthcare WestMicroburst electrical stimulation of cranial nerves for the treatment of medical conditions
US867083014 Mar 201311 Mar 2014Medtronic, Inc.Stimulation electrode selection
US867900915 Jun 201025 Mar 2014Flint Hills Scientific, LlcSystems approach to comorbidity assessment
US868492115 May 20121 Abr 2014Flint Hills Scientific LlcDetecting, assessing and managing epilepsy using a multi-variate, metric-based classification analysis
US871877724 Jul 20096 May 2014Advanced Neuromodulation Systems, Inc.Methods and systems for intracranial neurostimulation and/or sensing
US872523925 Abr 201113 May 2014Cyberonics, Inc.Identifying seizures using heart rate decrease
US873812610 Mar 200927 May 2014Catholic Healthcare WestSynchronization of vagus nerve stimulation with the cardiac cycle of a patient
US87684713 Mar 20131 Jul 2014Cyberonics, Inc.Dynamic cranial nerve stimulation based on brain state determination from cardiac data
US87815927 Sep 201115 Jul 2014Greatbatch Ltd.Identifying an area for electrical stimulation to treat a patient
US880551823 Ene 200912 Ago 2014Medtronic, Inc.Peripheral nerve field stimulation control
US882791227 Abr 20109 Sep 2014Cyberonics, Inc.Methods and systems for detecting epileptic events using NNXX, optionally with nonlinear analysis parameters
US883173230 Abr 20109 Sep 2014Cyberonics, Inc.Method, apparatus and system for validating and quantifying cardiac beat data quality
US88494093 Mar 201330 Sep 2014Cyberonics, Inc.Dynamic cranial nerve stimulation based on brain state determination from cardiac data
US885210025 Feb 20137 Oct 2014Flint Hills Scientific, LlcDetecting, quantifying, and/or classifying seizures using multimodal data
US886820326 Oct 200721 Oct 2014Cyberonics, Inc.Dynamic lead condition detection for an implantable medical device
US887421823 Abr 201328 Oct 2014Cyberonics, Inc.Neurostimulation with signal duration determined by a cardiac cycle
US88863235 Feb 201011 Nov 2014Medtronic, Inc.Electrical brain stimulation in gamma band
US88887023 Dic 201218 Nov 2014Flint Hills Scientific, LlcDetecting, quantifying, and/or classifying seizures using multimodal data
US892999119 Abr 20076 Ene 2015Advanced Neuromodulation Systems, Inc.Methods for establishing parameters for neural stimulation, including via performance of working memory tasks, and associated kits
US894279826 Oct 200727 Ene 2015Cyberonics, Inc.Alternative operation mode for an implantable medical device based upon lead condition
US894500624 Feb 20143 Feb 2015Flunt Hills Scientific, LLCDetecting, assessing and managing epilepsy using a multi-variate, metric-based classification analysis
US894885521 May 20133 Feb 2015Flint Hills Scientific, LlcDetecting and validating a detection of a state change from a template of heart rate derivative shape or heart beat wave complex
US900878014 Jun 201214 Abr 2015Case Western Reserve UniversityMethods and associated neural prosthetic devices for bridging brain areas to improve function
US902058230 Sep 201328 Abr 2015Flint Hills Scientific, LlcDetecting or validating a detection of a state change from a template of heart rate derivative shape or heart beat wave complex
US904298922 Ene 201426 May 2015Medtronic, Inc.Stimulation electrode selection
US904299022 Ene 201426 May 2015Medtronic, Inc.Stimulation electrode selection
US905046924 Nov 20049 Jun 2015Flint Hills Scientific, LlcMethod and system for logging quantitative seizure information and assessing efficacy of therapy using cardiac signals
US90670749 Jul 201330 Jun 2015Greatbatch Ltd.Automated search to identify a location for electrical stimulation to treat a patient
US907287025 Sep 20087 Jul 2015Medtronic, Inc.Sleep stage detection
US907290331 May 20117 Jul 2015Greatbatch Ltd.System and method of establishing a protocol for providing electrical stimulation with a stimulation system to treat a patient
US910804125 Nov 201318 Ago 2015Dignity HealthMicroburst electrical stimulation of cranial nerves for the treatment of medical conditions
US912604331 May 20118 Sep 2015Greatbatch Ltd.Patient handheld device for use with a spinal cord stimulation system
US914468031 May 201129 Sep 2015Greatbatch Ltd.System and method of establishing a protocol for providing electrical stimulation with a stimulation system to treat a patient
US91740487 Sep 20113 Nov 2015Greatbatch Ltd.Positioning leads on patient model using a graphical user interface
US921141117 Ago 201115 Dic 2015Medtronic, Inc.Therapy for rapid eye movement behavior disorder (RBD)
US92209107 Ene 201429 Dic 2015Cyberonics, Inc.Seizure detection using coordinate data
US923814210 Sep 201319 Ene 2016Great Lakes Neurotechnologies Inc.Movement disorder therapy system and methods of tuning remotely, intelligently and/or automatically
US924164721 Oct 201326 Ene 2016Cyberonics, Inc.Algorithm for detecting a seizure from cardiac data
US92482802 Nov 20072 Feb 2016Boston Scientific Neuromodulation CorporationClosed-loop feedback for steering stimulation energy within tissue
US924828814 Ene 20132 Feb 2016Medtronic, Inc.Patient directed therapy control
US92895993 Abr 201222 Mar 2016Dignity HealthVagus nerve stimulation method
US9289603 *10 Sep 201322 Mar 2016Great Lakes Neuro Technologies Inc.Movement disorder therapy system, devices and methods, and methods of remotely tuning
US931463331 Ago 201219 Abr 2016Cyberonics, Inc.Contingent cardio-protection for epilepsy patients
US93583907 Sep 20117 Jun 2016Nuvectra CorporationConfiguring electrical stimulation to treat a patient
US937557416 May 201428 Jun 2016Nuvectra CorporationSystem and method of providing computer assisted stimulation programming (CASP)
US9393418 *12 Abr 201319 Jul 2016Great Lakes Neuro Technologies Inc.Movement disorder therapy system, devices and methods of tuning
US940255029 Abr 20112 Ago 2016Cybertronics, Inc.Dynamic heart rate threshold for neurological event detection
US949816225 Abr 201122 Nov 2016Cyberonics, Inc.Identifying seizures using heart data from two or more windows
US950439013 Sep 201329 Nov 2016Globalfoundries Inc.Detecting, assessing and managing a risk of death in epilepsy
US95222789 Dic 201520 Dic 2016Great Lakes Neuro Technologies Inc.Movement disorder therapy system and methods of tuning remotely, intelligently and/or automatically
US953315024 Feb 20153 Ene 2017University Of KansasMethods and associated neural prosthetic devices for bridging brain areas to improve function
US953315110 Ene 20143 Ene 2017Dignity HealthMicroburst electrical stimulation of cranial nerves for the treatment of medical conditions
US95331558 Ene 20163 Ene 2017Axonics Modulation Technologies, Inc.Methods for determining neurostimulation electrode configurations based on neural localization
US955524614 Ago 201531 Ene 2017Axonics Modulation Technologies, Inc.Electromyographic lead positioning and stimulation titration in a nerve stimulation system for treatment of overactive bladder
US95613728 Ene 20167 Feb 2017Axonics Modulation Technologies, Inc.Electromyographic lead positioning and stimulation titration in a nerve stimulation system for treatment of overactive bladder
US958604721 Nov 20157 Mar 2017Cyberonics, Inc.Contingent cardio-protection for epilepsy patients
US959238528 Jul 201514 Mar 2017Nuvectra CorporationPatient handheld device for use with a spinal cord stimulation system
US96625023 Jun 201130 May 2017Great Lakes Neurotechnologies Inc.Method and system for tuning of movement disorder therapy devices
US97002567 Dic 201511 Jul 2017Cyberonics, Inc.Algorithm for detecting a seizure from cardiac data
US97069578 Jun 201518 Jul 2017Medtronic, Inc.Sleep stage detection
US97179205 Nov 20151 Ago 2017Great Lakes Neurotechnologies Inc.Movement disorder therapy system, devices and methods, and intelligent methods of tuning
US977020411 Nov 200926 Sep 2017Medtronic, Inc.Deep brain stimulation for sleep and movement disorders
US20030074032 *15 Oct 200217 Abr 2003Gliner Bradford EvanNeural stimulation system and method responsive to collateral neural activity
US20030088274 *30 Sep 20028 May 2003Vertis Neuroscience, Inc.Method and apparatus for electrically stimulating cells implanted in the nervous system
US20030125786 *27 Sep 20023 Jul 2003Gliner Bradford EvanMethods and apparatus for effectuating a lasting change in a neural-function of a patient
US20050033378 *9 Dic 200310 Feb 2005Sheffield Warren DouglasMethods for treating and/or collecting information regarding neurological disorders, including language disorders
US20050075679 *7 May 20047 Abr 2005Gliner Bradford E.Methods and apparatuses for treating neurological disorders by electrically stimulating cells implanted in the nervous system
US20060217780 *11 Oct 200528 Sep 2006Gliner Bradford EMethods for treating essential tremor
US20070088403 *19 Oct 200519 Abr 2007Allen WylerMethods and systems for establishing parameters for neural stimulation
US20070100398 *18 Oct 20063 May 2007Northstar Neuroscience, Inc.Neural stimulation system and optical monitoring systems and methods
US20070179558 *30 Ene 20062 Ago 2007Gliner Bradford ESystems and methods for varying electromagnetic and adjunctive neural therapies
US20070233192 *29 Mar 20074 Oct 2007Catholic Healthcare West (D/B/A St. Joseph's Hospital And Medical Center)Vagus nerve stimulation method
US20070233193 *29 Mar 20074 Oct 2007Catholic Healthcare West (D/B/A St. Joseph's Hospital And Medical Center)Microburst electrical stimulation of cranial nerves for the treatment of medical conditions
US20070233194 *29 Mar 20074 Oct 2007Catholic Healthcare West (D/B/A St. Joseph's Hospital And Medical Center)Synchronization of vagus nerve stimulation with the cardiac cycle of a patient
US20070244535 *18 Abr 200618 Oct 2007Cyberonics, Inc.Heat dissipation for a lead assembly
US20070255351 *28 Abr 20061 Nov 2007Cyberonics, Inc.Threshold optimization for tissue stimulation therapy
US20070265489 *19 Abr 200715 Nov 2007Northstar Neuroscience, Inc.Methods for establishing parameters for neural stimulation, including via performance of working memory tasks, and associated kits
US20080015641 *12 Jul 200617 Ene 2008Cyberonics, Inc.Implantable Medical Device Charge Balance Assessment
US20080183258 *26 Ene 200731 Jul 2008Inman D MichaelElectrode assembly with fibers for a medical device
US20080269839 *27 Abr 200730 Oct 2008Armstrong Randolph KDosing Limitation for an Implantable Medical Device
US20080319511 *22 Jun 200725 Dic 2008Neuropace, Inc.Auto adjusting system for brain tissue stimulator
US20090082829 *16 Oct 200726 Mar 2009Medtronic, Inc.Patient directed therapy control
US20090099622 *8 Abr 200816 Abr 2009Northstar Neuroscience, Inc.Methods and Systems for Establishing Neural Stimulation Parameters and Providing Neural Stimulation
US20090099627 *25 Sep 200816 Abr 2009Medtronic, Inc.Therapy control based on a patient movement state
US20090105785 *25 Sep 200823 Abr 2009Medtronic, Inc.Therapy program selection
US20090105786 *21 Oct 200823 Abr 2009University Of WashingtonMethod and device for strengthening synaptic connections
US20090112281 *5 Jun 200830 Abr 2009Medtronic, Inc.Medical device configuration based on sensed brain signals
US20090118786 *2 Nov 20077 May 2009Advanced Bionics CorporationAutomated fitting system for deep brain stimulation
US20090118787 *2 Nov 20077 May 2009Advanced Bionics CorporationClosed-loop feedback for steering stimulation energy within tissue
US20090118804 *5 Nov 20077 May 2009Advanced Bionics CorporationMethod of mounting minimally invasive plug electrodes within cranium of patient
US20090121989 *20 Oct 200814 May 2009Seiko Epson CorporationActive matrix device, electrooptic display, and electronic apparatus
US20090177252 *10 Mar 20099 Jul 2009Catholic Healthcare West (D/B/A St. Joseph's Hospital And Medical Center)Synchronization of vagus nerve stimulation with the cardiac cycle of a patient
US20090192556 *25 Sep 200830 Jul 2009Medtronic, Inc.Sleep stage detection
US20090264789 *28 Abr 200922 Oct 2009Medtronic, Inc.Therapy program selection
US20090281594 *23 Ene 200912 Nov 2009Medtronic, Inc.Peripheral Nerve Field Stimulation Control
US20100106217 *24 Oct 200829 Abr 2010Colborn John CDynamic cranial nerve stimulation based on brain state determination from cardiac data
US20100191304 *23 Ene 200929 Jul 2010Scott Timothy LImplantable Medical Device for Providing Chronic Condition Therapy and Acute Condition Therapy Using Vagus Nerve Stimulation
US20100192374 *8 Abr 20105 Ago 2010Cyberonics, Inc.Multi-Electrode Assembly for an Implantable Medical Device
US20100274308 *24 Abr 200928 Oct 2010Scott Timothy LUse of cardiac parameters in methods and systems for treating a chronic medical condition
US20110112590 *11 Nov 200912 May 2011Medtronic, Inc.Deep brain stimulation for sleep and movement disorders
US20110160795 *22 Mar 201030 Jun 2011Ivan OsorioSystem and apparatus for automated quantitative assessment, optimization and logging of the effects of a therapy
US20110190846 *13 Oct 20094 Ago 2011Starlab Barcelona,SlMulti-site cranial stimulation method and system
US20110196446 *5 Feb 201011 Ago 2011Medtronic, Inc.Electrical brain stimulation in gamma band
US20110224767 *23 May 201115 Sep 2011Cyberonics, Inc.Electrode assembly with fibers for a medical device
US20140005743 *12 Abr 20132 Ene 2014Joseph P. GiuffridaMovement disorder therapy system, devices and methods of tuning
WO2008130837A1 *8 Abr 200830 Oct 2008Northstar Neuroscience, Inc.Methods and systems for establishing neural stimulation parameters and providing neural stimulation
WO2009011947A1 *18 Abr 200822 Ene 2009Northstar Neuroscience, Inc.Methods for establishing parameters for neural stimulation, including via performance of working memory tasks, and associated kits
WO2009059041A1 *30 Oct 20087 May 2009Boston Scientific Neuromodulation CorporationClosed-loop feedback for steering stimulation energy within tissue
WO2009059197A1 *31 Oct 20087 May 2009Boston Scientific Neuromodulation CorporationAutomated fitting system for deep brain stimulation
WO2009137119A1 *23 Ene 200912 Nov 2009Medtronic, Inc.Peripheral nerve field stimulation control
WO2010018275A1 *13 Ago 200918 Feb 2010Starlab Barcelona, SlMulti-site cranial stimulation method and system
WO2011097210A1 *1 Feb 201111 Ago 2011Medtronic, Inc.Electrical brain stimulation in the gamma band
Clasificaciones
Clasificación de EE.UU.607/45
Clasificación internacionalA61N1/05, A61N1/34, A61N1/32, A61N1/36, A61N1/375
Clasificación cooperativaA61N1/36082, A61N1/36025, A61N1/0553, A61N1/3756, A61N1/0551, A61N1/36185, A61N1/36071, A61N1/375, A61N1/0531, A61N1/36021, A61N1/0534
Clasificación europeaA61N1/05K1C, A61N1/05K1D, A61N1/05L, A61N1/36Z, A61N1/36Z3C, A61N1/36Z5P3A, A61N1/36E4, A61N1/36Z3E, A61N1/36, A61N1/375
Eventos legales
FechaCódigoEventoDescripción
12 Jun 2009ASAssignment
Owner name: ADVANCED NEUROMODULATION SYSTEMS, INC., TEXAS
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:NORTHSTAR NEUROSCIENCE, INC.;REEL/FRAME:022813/0542
Effective date: 20090521
Owner name: ADVANCED NEUROMODULATION SYSTEMS, INC.,TEXAS
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:NORTHSTAR NEUROSCIENCE, INC.;REEL/FRAME:022813/0542
Effective date: 20090521